Improving clinical decision making by developing new paradigms for patient journey phenotyping
The Clinical Phenotyping Centre (CPC) aims to provide doctors with better information at each stage of a patient's treatment, helping them diagnose illness more efficiently and choose the best treatments based on a patient’s individual metabolic and physiological characteristics. It brings together state-of-the-art metabolic phenotyping capabilities and the integration and correlation of the data with other data sets on the same samples. The facility includes cutting-edge Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) infrastructure, as well as core analytical and project management staff.
The CPC is a core facility of the NIHR Imperial Biomedical Research Centre's (BRC) Institute of Translational Medicine and Therapeutics (ITMAT) funding scheme as well as part of the Molecular Phenomics cross-cutting theme for screening and monitoring patients in the surgical and hospital medical environments using multiple spectroscopic platforms to enhance clinical decision making.
The Centre and it links closely with the MRC-NIHR National Phenome Centre (NPC) and with Computational and Systems Medicine (CSM) within the Department of Surgery and Cancer and Professor Zoltan Takats is the Director.